Xiangxue Pharmaceutical Co (SZSE:300147) Cash per Share : ¥0.09 (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Xiangxue Pharmaceutical Co's Cash per Share for the quarter that ended in Mar. 2025 was ¥0.09.

Xiangxue Pharmaceutical Co Cash per Share Historical Data

The historical data trend for Xiangxue Pharmaceutical Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangxue Pharmaceutical Co Cash per Share Chart

Xiangxue Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash per Share

Get a 7-Day Free Trial

0.94

0.40

0.25

0.23

0.20

Xiangxue Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash per Share	Get a 7-Day Free Trial															0.18	0.16	0.11	0.20	0.09

Xiangxue Pharmaceutical Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Xiangxue Pharmaceutical Co's Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	131.741	/	661
	=	0.20

Xiangxue Pharmaceutical Co's Cash per Share for the quarter that ended in Mar. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	57.521	/	661
	=	0.09

Xiangxue Pharmaceutical Co (SZSE:300147) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Xiangxue Pharmaceutical Co Cash per Share Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiangxue Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663

Website

http://www.xphcn.com

Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.

Executives

Huang Wei Hua	Supervisors
Tan Wen Hui	Director
Kang Zhi Ying	Executives
Ceng Lun	Executives
Liu Yan	Executives
Lu Feng	Executives
Xu Li	Secretary, Director
Mo Zi Yu	Supervisors
Mai Zhen Jiang	Supervisors
Wang Yong Hui	Directors, executives
He Tao	Executives
Fang Wei Min	Supervisors
Huang Bin	Directors, Directors, and Executives
Wu Jun	Executives
Chen Wen Jin	Executives

Xiangxue Pharmaceutical Co Headlines

No Headlines